Review
Accepted on 04 Apr 2025
Dual roles of methylglyoxal in cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1557162
Type at least 3 characters
1,859 articles
Case Report
Accepted on 03 Apr 2025
Case report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1481602
Review
Accepted on 03 Apr 2025
Recent Advances in Therapeutic Use of Transforming Growth Factor-Beta Inhibitors in Cancer and Fibrosis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1489701
Review
Published on 01 Apr 2025
Advancements in research on the precise eradication of cancer cells through nanophotocatalytic technology
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1523444
- 225 views
Original Research
Published on 31 Mar 2025
Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1524714
- 218 views
Review
Published on 31 Mar 2025
The role and regulatory mechanism of lysosome associated protein transmembrane 4β in tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1552007
- 163 views
Perspective
Accepted on 28 Mar 2025
Bringing Value to Cancer Research
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1580575
Original Research
Accepted on 28 Mar 2025
Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1538335
Case Report
Published on 28 Mar 2025
Case Report: Personalized diagnosis and treatment strategies for three cases of cancer of unknown primary based on molecular testing techniques
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1505271
- 207 views
Review
Accepted on 27 Mar 2025
Epigenetic insights into Prostate Cancer: Exploring histone modifications and their therapeutic implications
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1570193
- 108 views
Systematic Review
Published on 26 Mar 2025
Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1552914
- 273 views
Review
Accepted on 25 Mar 2025
The Role and Clinical Significance of Tumor-Associated Macrophages in the Epithelial-Mesenchymal Transition of Lung Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1571583
Original Research
Accepted on 24 Mar 2025
PITX1 as a grading, prognostic and Tumor-infiltrating Immune Cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1477649
Review
Accepted on 24 Mar 2025
The biological role and molecular mechanism of transfer RNA-derived small RNAs in tumor metastasis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1560943
Original Research
Published on 24 Mar 2025
A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1511564
- 292 views
Original Research
Published on 24 Mar 2025
Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1399956
- 342 views